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Introduction
 Chromosome segregation in mitosis depends on 
kinetochores, complex protein structures that as-
semble at the centromeres of chromosomes1.  Ki-
netochores play a signiﬁcant role in the checkpoint 
mechanism that delays the onset of anaphase un-
til all chromosomes achieve bipolar attachments2. 
Kinetochore proteins can be divided into constitu-
tive proteins (CENP-A, CENP-B and CENP-C), 
which associate with the centromere throughout 
the cell cycle and faculative kinetochore proteins 
(CENP-E and CENP-F), which have a transient 
association with the centromere during mitosis3–6. 
CENP-A is a histone H3 homolog that is concen-
trated in the chromatin of the inner kinetochore 
plate of human chromosomes4.  CENP-C is a com-
ponent of the human inner kinetochore plate, 
which is closely associated with centromeric het-
erochromatin5.  CENP-E associates with kineto-
chores during congression, relocates to the spindle 
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Abstract : There have been very few studies on the expression of Centromere proteins in human 
salivary gland carcinomas.  The purpose of this study was to clarify the correlation between Cen-
tromere protein H (CENP-H) expression and clinicopathologic factors in salivary gland carcinomas.  
The expression of CENP-H mRNA was investigated in 28 human salivary gland tumors (7 pleo-
morphic adenomas, 3 Warthin tumors, 6 mucoepidermoid carcinomas, 6 adenoid cystic carcinomas, 
5 acinic cell carcinomas and 1 malignant myoepithelioma) and 8 normal submandibular glands us-
ing real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR).  The labeling 
index of PCNA and Ki-67 were also investigated immunohistochemically in 16 salivary gland carci-
nomas. The mean expression level of CENP-H mRNA was signiﬁcantly higher in malignant tumors 
(0.55± 0.68) than normal submandibular glands (0.10± 0.029).  A signiﬁcant correlation between 
the PCNA labeling index and CENP-H mRNA expression was also found (Spearman's correlation 
coefﬁcient by rank test, P=0.033).  We also found a signiﬁcant correlation between the Ki-67 label-
ing index and CENP-H mRNA expression in malignant tumors (Spearman's correlation coefﬁcient 
by rank test, P=0.040).  These results indicate that human CENP-H mRNA is closely linked to in-
creased or abnormal cell proliferation in malignant salivary gland tumors.
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midzone at anaphase, and is quantitatively dis-
carded at the end of the cell division6.   CENP-F is 
a human nuclear matrix protein with multiple 
leucine zipper motifs and accumulation in S-G2 
phases7.  CENP-F plays several signiﬁcant roles in 
mitotic events, including centromere/kinetochore 
maturation, chromosome alignment and segrega-
tion, and anaphase spindle stabilization7.  CENP-
G is a constitutive centromere-speciﬁc protein lo-
calized to the kinetochore inner plate and 
associates with the alpha-1 subfamily of alpha-
satellite DNA8. 
 Recently, a number of new kinetochore compo-
nents have been identiﬁed.  CENP-H is a protein 
of the fundamental components of the centromere-
kinetochore complex throughout the cell cycle, lo-
calized outside centromeric heterochromatin9. 
Confocal microscopic analysis revealed that 
CENP-H was present at the inner kinetochore 
plate and colocalizes with CENP-A and CENP-C 
in both interphase and metaphase10.  Fukagawa et 
al. investigated the role of CENP-H in centromere 
function and assembly by generating a conditional 
loss-of-function mutant in the chicken DT40 cell 
line11.  In the absence of CENP-H, cell cycle arrest 
at metaphase, consistent with loss of centromere 
function, was observed11.  Their ﬁndings suggests 
that CENP-H plays an important role in kineto-
chore organization and function throughout the 
cell cycle.
 Recently, overexpression of CENP-H has been 
reported in human colorectal and nasopharyngeal 
cancers12,13.  We have also reported that the ex-
pression of CENP-H mRNA was increased in hu-
man oral squamous cell carcinomas14.  However, 
no attempt has been made to investigate the ex-
pression of the CENP-H gene in human salivary 
gland tumors.  In this study, we examined the ex-
pression of human CENP-H mRNA in salivary 
gland carcinomas to clarify the correlation be-
tween CENP-H gene and clinicopathologic param-
eters.
Materials and Methods
Tissue samples
 We examined 28 salivary gland tumors : seven 
pleomorphic adenomas, three Warthin tumors, six 
mucoepidermoid carcinomas, six adenoid cystic 
carcinomas, ﬁve acinic cell carcinomas, and one 
malignant myoepithelioma.  Tumors were classi-
ﬁed according to the criteria of the Armed Forces 
Institute of Pathology's classiﬁcation of salivary 
gland tumors15.   Out of the 18 salivary gland car-
cinomas, 4 carcinomas (2 mucoepidermoid carcino-
mas and 2 adenoid cystic carcinomas) showed local 
lymph node metastasis.  Salivary gland tumor tis-
sues and specimens of normal salivary glands 
were obtained with informed consent and approval 
from the institutional review board at Hiroshima 
University Dental Hospital (Japan).  For molecu-
lar analyses, tissue samples obtained at the time 
of surgery were frozen immediately in liquid nitro-
gen and stored at –80℃.  We conﬁrmed microscop-
ically that the tumor specimens consisted mainly 
of carcinoma tissue and that the specimens of nor-
mal submandibular glands did not exhibit any tu-
mor cell invasion or show signiﬁcant inﬂammatory 
involvement.
RNA extraction and quantitative RT-PCR 
analysis
 RNA was extracted with an RNAeasy Mini Kit 
(QIAGEN, Hilden, Germany).  One microgram of 
total RNA was subjected to a reverse-transcriptase 
reaction using the First Strand cDNA Synthesis 
kit (Amersham Biosciences, Uppsala, Sweden). 
mRNA levels were quantitated using a real-time 
ﬂuorescence detection method16,17.  Fluorescence 
was detected using the laser detector of the Fluo-
rescent Quantitative Detection System (LineGene 
FQD-33A, Bio Flux, Tokyo, Japan) and detection 
was carried out by measuring the binding of a ﬂu-
orescent dye, SYBR Green I, to double-stranded 
DNA.  PCR was run in microtubes at a volume of 
20 μl.  The reaction mixture contained 1.0 μg of 
cDNA, 10 μl of SYBR Green PCR Master Mix 
(Toyobo, Osaka, Japan), and 10 pmol of each pair 
of oligonucleotide primers.  The primer sequences 
were : CENP-H ; 5'-TGCAAGAAAAGCAAATC-
GAA-3' (sense), 5'-ATCCCAAGATTCCTGCTGTG 
-3' (antisense), and G3PDH; 5'- ACCACAGTCCA-
TGCCATCAC-3' (sense), 5'-TCCACCACCCTGTG-
GCTGTA-3' (antisense).  The PCR program was as 
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follows : initial melting at 95℃ for 30 sec followed 
by 40 cycles at 95℃ for 15 sec, 55℃ for 10 sec and 
72℃ for 15 sec.  To conﬁrm ampliﬁcation speciﬁci-
ty, the PCR products were subjected to subsequent 
agarose gel electrophoresis.  The threshold cycle 
(CT) of each PCR product was deﬁned as the cycle 
number at which the ﬂuorescence signal passed 
the ﬁxed threshold.  Duplicate samples for each 
case were examined.  The 2－Δ
ct
  method is a conve-
nient way to analyze the relative changes in gene 
expression from real-time PCR experiments as de-
scribed previously18.  The average CT value was 
calculated for both CENP-H and G3PDH and ΔCT 
(Average of CENP-H CT value – Average of G3P-
DH CT value) was determined.  The relative 
quantiﬁcation of CENP-H mRNA was calculated 
as 2－Δ
ct
.
Immunohistochemistry
 Immunohistochemical staining was performed 
by the immunoperoxidase technique19 following 
antigen retrieval with microwave treatment 
(500W, 10 min) in citrate buffer pH 6.0.  After per-
oxidase block by 3% H2O2 –methanol for 10 min, 
specimens were blocked with PBS containing 5% 
normal horse serum (Vector Laboratories, Inc., 
Burlingame, CA).  For the staining of CENP-H, 
anti-CENP-H polyclonal antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA) was used (diluted 
1 :100).  After 2 hours incubation at room tempera-
ture with primary antibody, specimens were 
rinsed brieﬂy with PBS and incubated with sec-
ondary antibody for 1 hour at room temperature. 
Specimens were rinsed with PBS and incubated 
with DAB (DAKO Corp, Tokyo, Japan).  For the 
PCNA and Ki-67 labeling index, anti-PCNA mono-
clonal antibody (MBL, Nagoya, Japan) and anti-
Ki-67 monoclonal antibody (DAKO Corp, Tokyo, 
Japan) were used (diluted 1 :100).  The proportion 
of tumor cell nuclei stained by CENP-H, PCNA or 
Ki-67 was calculated for each tumor in x200 mi-
croscopic ﬁelds.  All tumor cell nuclei that stained 
brown above the background level, regardless of 
intensity, were considered positively stained.  We 
presented the positive cell ratio as the number of 
tumor cells immunostained per more than 1000 
carcinoma cells. CENP-H staining was graded as 
high (at least 10% of tumor cells showed moderate 
to intense immunoreactivity) or low (less than 
10% of tumor cells showed weak or no immunore-
activity).
Statistical methods
 The results of quantitative RT-PCR analysis 
were compared with patient clinicopathological in-
formation by the Mann-Whitney U test, Kruskal-
Wallis test and Spearman's correlation coefﬁcient 
by rank test.  P values of less than 0.05 were re-
garded as statistically signiﬁcant.    
Results
 The results of quantitative RT-PCR analysis are 
summarized in Tables 1 and 2.  The mean expres-
sion level of CENP-H mRNA was higher in malig-
nant tumors (0.55± 0.68) than normal subman-
dibular glands (0.10± 0.029) and benign tumors 
(0.14± 0.70), as shown in Fig. 1.  Malignant tu-
mors showed high levels of CENP-H mRNA ex-
pression compared to normal submandibular 
Table 1 Expression of CENP-H mRNA in normal sub-
mandibular gland and benign salivary gland tu-
mors.
Location CENP-H mRNA1
Normal salivary gland
Submandibular gland 0.08
Submandibular gland 0.10
Submandibular gland 0.09
Submandibular gland 0.12
Submandibular gland 0.07
Submandibular gland 0.16
Submandibular gland 0.08
Submandibular gland 0.10
Pleomorphic adenoma
Palate 0.12 
Palate 0.18
Palate 0.20 
Palate 0.20
Parotid gland 0.27
Parotid gland 0.08
Submandibular gland 0.03
Warthin tumor
Parotid gland 0.10
Parotid gland 0.11 
Parotid gland 0.12
1CENP-H mRNA, level of CENP-H mRNA expression was 
normalized with respect to internal control (G3PDH).
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Table 2 Expression of CENP-H mRNA in malignant salivary gland tumors. 
Location Stage1 Metastasis2
CENP-H expression Labeling index(%)
mRNA3 protein4 PCNA Ki-67
Mucoepidermoid carcinoma
Maxilla IV +  2.07 High 29.9 32.5
Palate  I －  1.49 High 11.8 2.3
Mandible IV －  0.22 Low 21.9 5.3
Oral ﬂoor II －  0.07 Low 13.6 9.1
Oral ﬂoor I －  0.13 Low 42.3 16
Parotid gland  IV +  0.48 Low N.D. N.D.
Acinic cell carcinoma
Maxilla II －  0.63  High 37.4 18.6
Buccal mucosa II －  0.17  N.D. N.D. N.D.
Parotid gland I －  0.05  Low 3.4 3.9
Parotid gland  III －  0.07  Low 18.9 10.9
Parotid gland I －  0.11  Low 2.8 0.87
Adenoid cystic carcinoma
Oral ﬂoor III + 0.46 Low 5.5 3.6
Oral ﬂoor II － 0.03 Low 3.9 1.85
Oral ﬂoor IV + 0.13  Low 10.7 3.13
Oral ﬂoor I － 2.15  High 35.1 20.4
Buccal mucosa IV － 0.15  Low 9.2 3.5
Submandibular gland  III － 1.02  N.D. N.D. N.D.
Malignant myoepithelioma
 Palate IV － 0.49  High 20.7 11.8
1Stage, tumor stages were determined according to the American Joint Committee on Cancer Staging Manual, 5th 
edn. 2Metastasis +, local lymph node metastasis ; －, negative lymph node metastasis. 3CENP-H mRNA, level of 
CENP-H mRNA expression was normalized with respect to internal control (G3PDH). 4protein, CENP-H protein ex-
pression was graded as high (at least 10% of tumor cells showed moderate to intense immunoreactivity) or low (less 
than 10% of tumor cells showed weak or no immunoreactivity) by immunohistochemical analysis. N.D., not deter-
mined.
Fig. 1 Levels of CENP-H mRNA expression in normal submandib-
ular glands, benign salivary gland tumors and malignant 
salivary gland tumors. Each point represents the CENP-H 
mRNA expression level. 
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glands, and signiﬁcant association was found 
(Mann-Whitney U test, P=0.046).  The expression 
of CENP-H mRNA was not correlated to clinico-
pathological factors such as age, gender, tumor 
type and tumor location.  Data on CENP-H mRNA 
expression, tumor size, clinical stage and lymph 
node metastasis are summarized in Table 3.  No 
signiﬁcant association was found between the lev-
el of CENP-H mRNA expression and tumor size or 
clinical stage.  Tumors with lymph node metasta-
sis showed higher levels of CENP-H mRNA ex-
pression than those without metastasis, although 
no signiﬁcant association was found. 
 To investigate the expression of CENP-H pro-
tein, we performed immunohistochemical staining 
of CENP-H.  Normal submandibular glands and 
benign tumors showed weak or no immunoreactiv-
ity for CENP-H (Fig. 2).  Two of 6 mucoepidermoid 
carcinomas, 1 of 4 acinic cell carcinomas, 1 of 5 ad-
enoid cystic carcinomas, and 1 of 1 malignant 
myoepithelioma showed high expression of CENP-
H protein, as shown in Fig. 2.  Five out of 6 carci-
nomas with high expression level of CENP-H 
mRNA showed positive expression of CENP-H 
protein.  However, one adenoid cystic carcinoma 
case with high expression level of CENP-H mRNA 
(expression level : 0.46) showed negative expres-
sion of CENP-H protein.  The expression levels of 
CENP-H protein were well correlated with the 
levels of CENP-H mRNA in salivary gland carci-
nomas as shown in Table 2.  
 We examined the labeling index of PCNA and 
Ki-67 in malignant salivary gland tumors immu-
nohistochemically to investigate the correlation 
between CENP-H mRNA expression and tumor-
proliferating activity.  The average CENP-H 
mRNA expressions in cases with a high PCNA la-
beling index (5% or greater) and with a low label-
ing index (less than 5%) were 0.67± 0.78 and 
0.063± 0.041, respectively, indicating signiﬁcant 
correlation between the PCNA labeling index and 
CENP-H mRNA expression in salivary gland car-
cinomas (Spearman's correlation coefﬁcient by 
rank test, P=0.033) (Fig. 3).  The average CENP-H 
mRNA expressions in cases with a high Ki-67 la-
beling index (5% or greater) and a low labeling in-
dex (less than 5%) were 0.73± 0.88 and 0.35±
0.52, respectively.  Signiﬁcant correlation between 
the Ki-67 labeling index and CENP-H mRNA ex-
pression was found in malignant salivary gland 
tumors (Spearman's correlation coefﬁcient by rank 
test, P=0.040) (Fig. 4). 
Table 3 Expression of CENP-H mRNA in salivary gland carcinomas and its 
correlation with clinicopathological parameters.
 Case number
Expression level of CENP-H
Mean± SD P value2
Tumor size1
T1 5  0.78± 0.97 0.67
T2 6  0.34± 0.29  
T3 1 0.102
T4 6  0.59± 0.74
Clinical stage1
 I 5  0.79± 0.97
 II 4  0.23± 0.28  0.68
 III 3  0.52± 0.48
 IV 6  0.59± 0.74
Lymph node metastasis
Positive 5  0.64± 0.82  0.83
Negative 13  0.54± 0.68
1According to the American Joint Committee on Cancer Staging Manual, 5th 
edn. 2P value, the correlation was analyzed using the Kruskal-Wallis test or 
Mann-Whitney U test and p values are shown. P values less than 0.05 were 
regarded as statistically signiﬁcant.
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Fig. 3 Correlation between the PCNA labeling index and CENP-H 
mRNA expression in malignant salivary gland tumors. A sig-
niﬁcant correlation was found between the PCNA labeling 
index and CENP-H (Spearman's correlation coefﬁcient by 
rank test, P=0.033).
Fig. 2 Immunohistochemistry of CENP-H and PCNA in salivary gland carcinomas. (A) Expression of CENP-H in normal sub-
mandibular glands. (B) Expression of CENP-H in mucoepidermoid carcinomas. Tumor cells (solid type) showed CENP-H 
positive expression. (C) Expression of CENP-H in malignant myoepithelioma. Myoepithelial cells showed CENP-H posi-
tive expression. (D) Expression of CENP-H in acinic cell carcinomas. Aciner cells showed CENP-H positive expression. 
(E) Expression of PCNA in acinic cell carcinomas. Aciner cells showed PCNA positive expression.
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Discussion
 Salivary gland tumors are uncommon and have 
broad heterogeneity20.  Salivary gland carcinomas 
showed several variations even in the same histo-
logical type21–23.  Adenoid cystic carcinomas are 
classiﬁed by their histologic patterns into tubular, 
cribriform, and solid forms.  Histopathologically, 
the cribriform subtype was associated with multi-
ple local recurrences and a poor salvage rate as 
compared with the tubular subtype21.  Mucoepi-
dermoid carcinomas display a widely diverse bio-
logical behavior.  High-grade mucoepidermoid car-
cinoma is a highly aggressive tumor while low-
grade mucoepidermoid carcinoma shows a more 
benign nature22,23.  Despite understanding of the 
clinical and biological behavior of histological sub-
type in salivary gland carcinomas, the genetic 
mechanism of pathogenesis of each sub-type is not 
well understood.  In this study, we examined the 
expression of CENP-H mRNA in salivary gland 
benign and malignant tumors.  Four malignant 
tumors (2 mucoepidermoid carcinomas and 2 ade-
noid cystic carcinomas) showed high levels of 
CENP-H mRNA expression compared to normal 
submandibular glands.  The correlation of histo-
logical sub-type and expression levels of CENP-H 
mRNA in each type of carcinoma could not be clar-
iﬁed.  Since the number of cases of each type of 
salivary gland carcinoma investigated in this 
study was relatively small, further analysis is 
needed to clarify the correlation between CENP-H 
mRNA expression and histological sub-type in 
each type of carcinoma.
 CENP-F is a nuclear matrix component that lo-
calizes to kinetochores during mitosis and is then 
rapidly degraded after mitosis7.  We have reported 
that there was a signiﬁcant correlation between 
the expression of CENP-F and the Ki-67 labeling 
index in salivary gland tumors24.  We have also re-
ported that CENP-F mRNA levels were higher in 
patients with oral SCCs harboring lymph node 
metastasis than in cases without metastasis25. 
These observations suggest that CENP-F gene is a 
useful diagnostic marker for salivary gland carci-
nomas and oral SCCs.
 In the present study, we examined the expres-
sion of PCNA protein and Ki-67 as a marker for 
cell proliferating activity.  PCNA, an auxiliary 
protein for DNA polymerase Δ, plays an important 
role in DNA synthesis and is thought to be local-
ized to nuclei, particularly during late G and S 
phases26.  Therefore, the expression of PCNA is a 
useful marker in evaluating cell proliferating ac-
tivity.  We also examined the expression of Ki-67 
as a marker for cell proliferating activity.  Ki-67 
labeling indices have been used for the prognosis 
of various salivary gland carcinomas27,28.  We dem-
onstrated a signiﬁcant association between the ex-
pression level of CENP-H mRNA and the Ki-67 la-
beling index.  Our observations indicate that 
CENP-H mRNA might be a valuable marker as 
cell proliferating activity.
 Accurate chromosome segregation through mito-
sis requires the proper attachment of kinetochores 
to the spindle.  Kinetochores ensure high ﬁdelity 
chromosome segregation and delay the onset of 
anaphase until chromosomes achieve bipolar at-
tachments29,30.  Chromosomal instability is respon-
sible for abnormal chromosomal numbers, which 
is one of the cytogenetic characteristics of cancer 
cells31.  Abnormal chromosomal numbers are 
closely associated with catastrophic mitosis during 
tumor progression.  The frequent occurrence of 
aneuploidy in cancer cells might give rise to a mu-
tator phenotype and promote tumor develop-
Fig. 4 Correlation between the Ki-67 labeling in-
dex and CENP-H mRNA expression in ma-
lignant salivary gland tumors. A signiﬁcant 
correlation was found between the Ki-67 la-
beling index and CENP-H (Spearman's cor-
relation coefﬁcient by rank test, P=0.040).
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ment32,33.  Centromere proteins play an important 
role in kinetochore formation and sister chromatid 
separation.  Constitutive centromere proteins are 
found at the inner kinetochore throughout the cell 
cycle.  Human CENP-H has been identiﬁed and 
discovered to be a signiﬁcant constitutive compo-
nent of the centromere10.  The absence of CENP-H 
induced cell cycle arrest at metaphase and subse-
quent cell death in vertebrate cells11.  Other re-
ports showed that mitotic phenotypes such as mis-
aligned chromosomes and multipolar spindles 
were observed in CENP-H knocked-down cells34. 
These results suggest that CENP-H plays an im-
portant role in the cell cycle.  On the other hand, 
overexpression of CENP-H induces chromosome 
missegregation and aneuploidy in diploid colorec-
tal cancer cell lines12.  The results indicate the 
possibility that overexpression of CENP-H associ-
ates with chromosomal instability and tumorgene-
sis at the early stage of human cancers.  However, 
the essential role of the overexpressed CENP-H 
has not been fully elucidated in human cells. 
CENP-E interacts with hBUBR1, a BUB1-related 
kinase that localizes to the kinetochore and is re-
quired to properly arrest cell cycle progression fol-
lowing spindle damage35,36.  There are no reports 
that examined the association between CENP-H 
and spindle checkpoint kinase such as Bub1 gene. 
Further investigations are needed to clarify 
whether CENP-H contributes to the cell cycle 
checkpoint of M phase in human cells.
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